Адренорецепторы, их стимуляторы и блокаторы: литература

1. Berkowitz BA. Vascular relaxation and aging. In P Vanhoutte, I Leusen (eds), Mechanisms of Vasodilation. New York: Karger, 1978.

2. Brown AM. A cellular logic for G-protein coupled ion channel pathways. FASEBJ 5:2175, 1991.

3. Brown J, et al. Evidence for cardiac beta2-adrenoceptors in man. Clin Pharmacol Ther 33:424, 1983.

4. Caron M, Lefkowitz R. beta-Adrenergic receptors: Basic studies and clinical implications. In M Stein (ed.), New Directions in Asthma. Park Ridge, IL: American College of Chest Physicians, 1975.

5. Elliott HL, Reid JL. Evidence for post-junctional vascular alpha2-adren-oceptors in peripheral vascular regulation in man. Clin Sci 65:237, 1983.

6. Ford GA, et al. Age-related changes in adenosine and beta adrenoceptor responsiveness of vascular smooth muscle in men. Br J Clin Pharmacol 33:83, 1992.

7. Gilman AG. G-Proteins and regulation of adenylyl cyclase. JAMA 262:1819, 1989.

8. Glaubiger G, Lefkowitz R. Elevated beta-adrenergic receptor number after chronic propranolol treatment. Biochem Biophys Res Commun 78:720, 1977.

9. Harrison JK, et al. Molecular characterization of alphar and alpha2-adrenoceptors. Trends Pharmacol Sci 12:62, 1991.

10. Hausdorff W, et al. Turning off the signal: Desensitization of beta-adren-ergic function. FASEB J 4:2881, 1990.

11. Kenakin T. Drugs and receptors. Drugs 40:666, 1990.

12. Klein C, et al. The effect of age on the sensitivity of the alpha г -adrenoceptor to phenylephrine and prazosin. Clin Pharmacol Ther 47:535, 1990.

13. Langer SZ. Presynaptic receptors and their role in the regulation of trans-mitter release. Br J Pharmacol 60:481, 1977.

14. Lefkowitz R, et al. Hormones, receptors, and cyclic AMP: Their role in target cell refractoriness. Curr Top Cell Regul 17:205, 1980.

15. Levy JV. beta-adrenergic blocking drugs in spontaneous hypertension. Am J Med 61:779, 1976.

16. Plummer AL. Development of drug tolerance to beta2-adrenergic agents. Chest 73(Suppl):949, 1978.

17. Pool P, et al. Metabolic consequences of treating hypertension. Am J Hyperten 4:4945, 1991.

18. Prichard BN. alpha- and beta-blocking agents: Pharmacology and prop-erties. Cleve Clin J Med 58:337, 1991.

19. Ruffulo RR, et al. Structure and function of alpha adrenoceptors. Pharmacol Rev 43:475, 1991.

20. Tola MR, et al. Biophysical and genetic analysis of the ligand- binding site of the beta-adrenoceptor. Trends Pharmacol Sci 12:4, 1991.

Ссылки: